Because birth control pills and hormone replacement therapy raise estrogen levels, and estrogen promotes the small-blood-vessel growth behind cherry angiomas, some people notice more angiomas while taking them. The link is real but associative: it is not a reason to stop any medication, and any decision about your hormonal treatment should be made with your prescribing doctor. The angiomas themselves are benign and straightforwardly treatable at home.
For the full background on the estrogen-angiogenesis mechanism, see Why Hormones Cause Cherry Angiomas. This article answers the specific question of how exogenous (introduced-from-outside) hormones connect to cherry angiomas, what that means for your medication, and what you can do about the angiomas.
Key takeaways
Birth control and HRT raise estrogen. Estrogen promotes cherry angioma formation. The angiomas are benign and do not require stopping medication.
- Estrogen upregulates VEGF, a protein that drives new small-blood-vessel growth, which is how cherry angiomas form.
- Oral contraceptives and HRT both raise circulating estrogen, potentially accelerating that vessel growth.
- Cherry angiomas are benign vascular lesions: not a warning sign, not a contraindication to hormonal therapy.
- Cherry angiomas do not resolve on their own. A plasma pen cauterizes the vessel cluster in minutes, scabs Day 3-7, and clears Week 2-3.
- Never adjust hormonal medication based on cherry angiomas alone. Talk to your prescribing doctor.
How birth control and HRT raise estrogen
The estrogen baseline shift
Oral contraceptives contain synthetic estrogen (usually ethinylestradiol) and progestin. Their primary function is to suppress ovulation by maintaining stable, elevated hormone levels. As a direct result, circulating estrogen is higher than it would be in a natural cycle. The higher the estrogen dose in the formulation, the more pronounced this effect.
Hormone replacement therapy for menopause also introduces exogenous estrogen, with the goal of relieving symptoms caused by the body's own declining production. Estrogen-only HRT (used by women without a uterus) and combined estrogen-progestogen HRT both raise circulating estrogen above what the body is producing naturally at that stage.
Both interventions land in the same place: more estrogen circulating than the body would generate on its own, for as long as the treatment continues.
How exogenous estrogen fits the cherry angioma mechanism
Cherry angiomas form when estrogen upregulates vascular endothelial growth factor (VEGF), a signaling protein that prompts the body to grow new small blood vessels. That vessel-building process, called angiogenesis, is normal and useful in many contexts: it repairs tissue, supports pregnancy, and sustains wound healing. As a side effect, it also produces the benign capillary clusters visible as cherry angiomas.
The same mechanism operates whether estrogen is endogenous (produced by the ovaries) or exogenous (introduced by medication). This is why the estrogen in birth control or HRT can promote cherry angioma formation by the same biological route as naturally elevated estrogen during perimenopause or pregnancy. Per the American College of Obstetricians and Gynecologists, estrogen is a potent driver of vascular changes across multiple tissues. The skin is one of them.
For a closer look at how the estrogen-to-progesterone ratio factors in, see Cherry Angiomas and Estrogen Dominance.
Birth control vs HRT: the same mechanism, different context
The estrogen type and dose differ between oral contraceptives and HRT formulations, which means the cherry angioma impact is not identical across both.
Oral contraceptives
Higher-dose combined pills (older formulations) historically carried more vascular side effects than lower-dose modern pills. Lower-dose pills contain less ethinylestradiol and are less likely to drive pronounced angiogenesis, though the risk is not zero. Progestin-only pills ("mini-pill") do not contain estrogen and are not expected to promote cherry angiomas through an estrogen pathway.
Hormone replacement therapy
Estrogen-only HRT delivers a direct estrogen dose. Combined HRT (estrogen plus progestogen) partially offsets the estrogen signal depending on the progestogen used. The net angiogenic effect depends on the formulation and dose. Per the Mayo Clinic, HRT decisions involve multiple risk-benefit considerations beyond skin changes. Cherry angiomas alone are not a reason to adjust therapy.
The practical takeaway: both birth control and HRT can raise estrogen in a way that promotes cherry angiomas. The dose matters. The formulation matters. Your prescribing doctor is the right person to discuss both.
Do not change your medication based on cherry angiomas
- Cherry angiomas are benign. They are not a contraindication to hormonal therapy.
- Never stop birth control or HRT because of angiomas alone. Hormonal therapy involves a full risk-benefit calculation that requires your prescribing doctor.
- If the angiomas change rapidly, bleed without trauma, or look atypical, see a dermatologist to confirm what you are seeing.
- The angiomas are a cosmetic side effect, not a clinical warning sign.
What this means for your medication
The American Academy of Dermatology classifies cherry angiomas as common, benign vascular lesions. A dermatologist seeing cherry angiomas on a patient on HRT would not flag that as a contraindication. If you are bothered by the angiomas cosmetically, that is a separate and solvable question (see below). If you have concerns about your hormonal therapy for other reasons, those concerns deserve a full conversation with your prescribing doctor. But the angiomas alone are not the signal that something is wrong.
Why you may notice more angiomas after starting
Some people notice their first cherry angiomas, or a new cluster, within weeks of starting a hormonal medication. This pattern is consistent with the estrogen-angiogenesis mechanism: once the estrogenic signal is elevated, new vessel formation can begin relatively quickly. If you were already developing cherry angiomas from natural hormonal shifts, adding exogenous estrogen can accelerate that process.
For the general question of why cherry angiomas appear suddenly and in clusters, see Why Am I Suddenly Getting Cherry Angiomas. For the specific question of whether hormone-driven angiomas ever resolve on their own, see Do Hormone-Driven Cherry Angiomas Go Away on Their Own.
If you are in the perimenopausal transition and noticing cherry angiomas both from natural hormonal shifts and from HRT, see Cherry Angiomas and Perimenopause for the full picture of what that overlap looks like. For the broader hormonal skin context, see Hormonal Skin Changes.
Managing the angiomas themselves
What actually removes a cherry angioma
If the angiomas are bothering you cosmetically, the medication connection does not change what removes them. Cherry angiomas are formed capillary clusters sitting just under the skin. A plasma pen device delivers a controlled arc of plasma energy that cauterizes the vessel cluster directly, in a few minutes per spot. The spot scabs over between Day 3 and Day 7, and the skin renews by Week 2 to 3.
This is the same mechanism a dermatologist uses with in-office laser or electrocautery, in a consumer-grade form. Clinical treatment typically costs $500 to $2,000 per session. The NIH MedlinePlus skin conditions reference notes that benign vascular growths like cherry angiomas are commonly treated for cosmetic reasons without any underlying health intervention.
The medication question and the angioma question are separate. Your doctor handles one. A plasma pen handles the other.
The treatment and healing window
Removing a cherry angioma at home with a plasma pen does not require stopping or changing any medication. The treatment is local, non-systemic, and has no interaction with hormonal therapy.
Day 1
Treat and scab forms
5 minutes per spot. Apply numbing cream beforehand if preferred. Healing patches protect the scab.
The bottom line
Birth control and HRT raise estrogen, and estrogen promotes the small-vessel growth behind cherry angiomas. The association is real and it is not a clinical problem, not a warning sign, and not a reason to stop medication. The angiomas are benign and removable at home. Decisions about your hormonal therapy belong with your prescribing doctor, informed by the full picture of your health and not by a cosmetic skin change.
FAQ
Frequently asked questions
Common questions about birth control, HRT, and cherry angiomas.
Is there a quick-reference answer before the full accordion?
Yes. Cherry angiomas are benign capillary clusters. Estrogen in hormonal medications promotes their growth. They do not require stopping medication. They can be removed at home with a plasma pen.
↓ Tap each question to reveal the answer.
The medication question and the angioma question are separate. Your doctor handles one. A plasma pen handles the other.
28,000+
Customers served
90 days
Risk-free trial
At home
No clinic, no appointment
See real customer reviews, photos, and before-and-afters →
Built for benign vascular lesions
The OcuraLife Plasma Pen is built for this
Delivers focused plasma energy at the capillary cluster. Nine power settings, single-use sterile tips. A scab forms, falls off on its own, and the skin renews in two to three weeks.
See the Plasma Pen